JPWO2022004864A1 - - Google Patents
Info
- Publication number
- JPWO2022004864A1 JPWO2022004864A1 JP2021542548A JP2021542548A JPWO2022004864A1 JP WO2022004864 A1 JPWO2022004864 A1 JP WO2022004864A1 JP 2021542548 A JP2021542548 A JP 2021542548A JP 2021542548 A JP2021542548 A JP 2021542548A JP WO2022004864 A1 JPWO2022004864 A1 JP WO2022004864A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/50—Cell markers; Cell surface determinants
- C12N2501/599—Cell markers; Cell surface determinants with CD designations not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/10—Screening for compounds of potential therapeutic value involving cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Cell Biology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Developmental Biology & Embryology (AREA)
- Virology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Diabetes (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Obesity (AREA)
- General Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Urology & Nephrology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- General Physics & Mathematics (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2022040623A JP2022179822A (ja) | 2020-07-01 | 2022-03-15 | ヒト長期造血幹細胞マーカー |
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/JP2020/025915 WO2021131110A1 (ja) | 2018-12-28 | 2020-07-01 | 細胞階層化処理により特定の生物学的特徴を有する細胞を同定する方法およびその応用方法 |
JPPCT/JP2020/025915 | 2020-07-01 | ||
JP2021089502 | 2021-05-27 | ||
JP2021089502 | 2021-05-27 | ||
PCT/JP2021/025050 WO2022004864A1 (ja) | 2020-07-01 | 2021-07-01 | ヒト長期造血幹細胞マーカー |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2022040623A Division JP2022179822A (ja) | 2020-07-01 | 2022-03-15 | ヒト長期造血幹細胞マーカー |
Publications (2)
Publication Number | Publication Date |
---|---|
JPWO2022004864A1 true JPWO2022004864A1 (zh) | 2022-01-06 |
JP7215776B2 JP7215776B2 (ja) | 2023-01-31 |
Family
ID=79316434
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2021542548A Active JP7215776B2 (ja) | 2020-07-01 | 2021-07-01 | ヒト長期造血幹細胞マーカー |
JP2022040623A Pending JP2022179822A (ja) | 2020-07-01 | 2022-03-15 | ヒト長期造血幹細胞マーカー |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2022040623A Pending JP2022179822A (ja) | 2020-07-01 | 2022-03-15 | ヒト長期造血幹細胞マーカー |
Country Status (6)
Country | Link |
---|---|
US (1) | US20230279354A1 (zh) |
EP (1) | EP4177337A1 (zh) |
JP (2) | JP7215776B2 (zh) |
KR (1) | KR20230034299A (zh) |
CN (1) | CN116075311A (zh) |
WO (1) | WO2022004864A1 (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPWO2022255489A1 (zh) * | 2021-06-04 | 2022-12-08 | ||
WO2023222565A1 (en) * | 2022-05-16 | 2023-11-23 | Institut National de la Santé et de la Recherche Médicale | Methods for assessing the exhaustion of hematopoietic stems cells induced by chronic inflammation |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2019146584A (ja) * | 2011-06-02 | 2019-09-05 | プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ | エキソビボ組織培養システムのための方法および使用 |
WO2019208696A1 (ja) * | 2018-04-25 | 2019-10-31 | ネクスジェン株式会社 | 造血幹細胞における自己複製能関連遺伝子のスクリーニング方法および当該遺伝子の使用方法 |
JP2020500156A (ja) * | 2016-10-13 | 2020-01-09 | プレジデント アンド フェローズ オブ ハーバード カレッジ | 骨髄非破壊前処理のための組成物および方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PE20100362A1 (es) | 2008-10-30 | 2010-05-27 | Irm Llc | Derivados de purina que expanden las celulas madre hematopoyeticas |
-
2021
- 2021-07-01 CN CN202180053451.XA patent/CN116075311A/zh active Pending
- 2021-07-01 US US18/014,112 patent/US20230279354A1/en active Pending
- 2021-07-01 WO PCT/JP2021/025050 patent/WO2022004864A1/ja unknown
- 2021-07-01 JP JP2021542548A patent/JP7215776B2/ja active Active
- 2021-07-01 EP EP21834496.8A patent/EP4177337A1/en active Pending
- 2021-07-01 KR KR1020237001669A patent/KR20230034299A/ko unknown
-
2022
- 2022-03-15 JP JP2022040623A patent/JP2022179822A/ja active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2019146584A (ja) * | 2011-06-02 | 2019-09-05 | プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ | エキソビボ組織培養システムのための方法および使用 |
JP2020500156A (ja) * | 2016-10-13 | 2020-01-09 | プレジデント アンド フェローズ オブ ハーバード カレッジ | 骨髄非破壊前処理のための組成物および方法 |
WO2019208696A1 (ja) * | 2018-04-25 | 2019-10-31 | ネクスジェン株式会社 | 造血幹細胞における自己複製能関連遺伝子のスクリーニング方法および当該遺伝子の使用方法 |
Non-Patent Citations (2)
Title |
---|
INDUMATHI, S. ET AL.: "Exploring the stem cell and non-stem cell constituents of human breast milk", CYTOTECHNOLOGY, vol. 65, no. 3, JPN6021036667, 2013, pages 385 - 393, XP055897230, ISSN: 0004763027, DOI: 10.1007/s10616-012-9492-8 * |
NOTTA F. ET AL.: "Isolation of Single Human Hematopoietic Stem Cells Capable of Long-Term Multilineage Engraftment", SCIENCE, vol. 333, no. 6039, JPN6021036666, 2011, pages 218 - 221, XP055069664, ISSN: 0004763026, DOI: 10.1126/science.1201219 * |
Also Published As
Publication number | Publication date |
---|---|
US20230279354A1 (en) | 2023-09-07 |
WO2022004864A1 (ja) | 2022-01-06 |
CN116075311A (zh) | 2023-05-05 |
KR20230034299A (ko) | 2023-03-09 |
EP4177337A1 (en) | 2023-05-10 |
JP7215776B2 (ja) | 2023-01-31 |
JP2022179822A (ja) | 2022-12-05 |
Similar Documents
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20210721 |
|
A871 | Explanation of circumstances concerning accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A871 Effective date: 20210721 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20211116 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20211216 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20220111 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20220315 |
|
C60 | Trial request (containing other claim documents, opposition documents) |
Free format text: JAPANESE INTERMEDIATE CODE: C60 Effective date: 20220315 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20220324 |
|
C21 | Notice of transfer of a case for reconsideration by examiners before appeal proceedings |
Free format text: JAPANESE INTERMEDIATE CODE: C21 Effective date: 20220329 |
|
A912 | Re-examination (zenchi) completed and case transferred to appeal board |
Free format text: JAPANESE INTERMEDIATE CODE: A912 Effective date: 20220506 |
|
C211 | Notice of termination of reconsideration by examiners before appeal proceedings |
Free format text: JAPANESE INTERMEDIATE CODE: C211 Effective date: 20220510 |
|
C876 | Explanation why request for accelerated appeal examination is justified |
Free format text: JAPANESE INTERMEDIATE CODE: C876 Effective date: 20220531 |
|
C305 | Report on accelerated appeal examination |
Free format text: JAPANESE INTERMEDIATE CODE: C305 Effective date: 20220602 |
|
C22 | Notice of designation (change) of administrative judge |
Free format text: JAPANESE INTERMEDIATE CODE: C22 Effective date: 20220607 |
|
C13 | Notice of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: C13 Effective date: 20220705 |
|
C22 | Notice of designation (change) of administrative judge |
Free format text: JAPANESE INTERMEDIATE CODE: C22 Effective date: 20220802 |
|
C302 | Record of communication |
Free format text: JAPANESE INTERMEDIATE CODE: C302 Effective date: 20220817 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20220901 |
|
C13 | Notice of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: C13 Effective date: 20220913 |
|
C30 | Protocol of an oral hearing |
Free format text: JAPANESE INTERMEDIATE CODE: C30 Effective date: 20221018 |
|
C302 | Record of communication |
Free format text: JAPANESE INTERMEDIATE CODE: C302 Effective date: 20221108 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20221109 |
|
C23 | Notice of termination of proceedings |
Free format text: JAPANESE INTERMEDIATE CODE: C23 Effective date: 20221122 |
|
C03 | Trial/appeal decision taken |
Free format text: JAPANESE INTERMEDIATE CODE: C03 Effective date: 20221220 |
|
C30A | Notification sent |
Free format text: JAPANESE INTERMEDIATE CODE: C3012 Effective date: 20221220 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20230112 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 7215776 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |